Finance

Beta
Lists
GALT:NASDAQ
Galectin Therapeutics Inc. Common Stock
$2.40
+3.00%
(+0.070) 1D
$2.42
+0.83% (+0.020)
After hours
Closed: Jun 8, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GALT...
Open
$2.35
High
$2.43
Low
$2.34
Mkt. cap
158.06M
Avg. vol.
318.82K
Volume
0.00
52-wk high
$7.13
52-wk low
$1.28
EPS
-$0.41
Beta
0.47
Shares outstanding
65.86M
No. of employees
9
Open
$2.35
High
$2.43
Low
$2.34
Mkt. cap
158.06M
Avg. vol.
318.82K
Volume
0.00
52-wk high
$7.13
52-wk low
$1.28
EPS
-$0.41
Beta
0.47
Shares outstanding
65.86M
No. of employees
9
Analyst outlook
Analyst Ratings
Based on 1 analyst giving stock ratings to GALT in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12 month forecast
Based on 1 Wall Street analyst offering 12 month price targets for GALT in the last 3 months.
Highest
Current $2.40
$11.00 (+358.33%)
Average
$11.00 (+358.33%)
Lowest
$11.00 (+358.33%)
News stories
From sources across the web
About Galectin Therapeutics Inc. Common Stock
CEO-
Employees9
Founded2000
HeadquartersNorcross, Georgia, United States
SectorBiotechnology
Websitegalectintherapeutics.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
3.26M
2.61M
1.93M
2.23M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.36M
1.59M
1.43M
1.85M
Operating expense
4.62M
4.20M
3.36M
4.08M
Total operating expenses
4.62M
4.20M
3.36M
4.08M
Operating income
-4.62M
-4.20M
-3.36M
-4.08M
Other non operating income
-1.10M
-2.20M
-221.00K
983.00K
EBT including unusual items
-7.52M
-8.18M
-5.50M
-5.05M
EBT excluding unusual items
-7.52M
-8.18M
-5.50M
-5.05M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-7.52M
-8.18M
-5.50M
-5.05M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
26.00K
39.00K
25.00K
36.00K
Interest expense
-1.83M
-1.82M
-1.94M
-1.99M
Net interest expenses
-1.80M
-1.78M
-1.91M
-1.95M
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer